Home
|
Contact
|
Français
About
What is CAPA
Why
Where
How
Guidance Documents
Annual Reports
Steering Committee
Get Involved
Events
Upcoming & Ongoing Events
Events Archive
Resources
Access to Medications
Access to Professionals
Briefcase
Communication
Disability Issues
Education
Library
Member Outreach
Messages from the President
Political Action
Research
Telling it Like It Is
Links
News
CAPA Voices
Let's Talk
Resources
home
>
resources
> Public involvement a “first” for Health Canada: Expert Advisory Panel reviews COX-2 evidence
Access to Medications
Access to Professionals
Briefcase
Communication
Disability Issues
Education
Library
Member Outreach
Messages from the President
Political Action
Research
Telling it Like It Is
Links
Foward to a friend
Public involvement a “first” for Health Canada: Expert Advisory Panel reviews COX-2 evidence
Required information is indicated by
*
.
to
email address
*
Separate multiple address with a comma (,)
your details
email address
*
name
*
message
I thought you would be interested in reading this article. Public involvement a “first” for Health Canada: Expert Advisory Panel reviews COX-2 evidence Health Canada opened up its drug review process to the public when it held its Expert Advisory Panel (EAP) and Public Forum on the selective COX-2 inhibitors in Ottawa on June 9th. The EAP heard and questioned pharmaceutical drug company presentations in public and included public input as part of the evidence being considered. Article URL: http://www.arthritispatient.ca/index.php/resources/public-involvement-a-first-for-health-canada-expert-advisory-panel-reviews-/ Canadian Arthritis Patient Alliance http://www.arthritispatient.ca/
image verification
*
Please enter the word you see in the image above